Bergenbio ASA (BGBIO) — Financial Flexibility Index
Bergenbio ASA (BGBIO) has a Financial Flexibility Index of -4.63x as of December 2024. Free cash flow of Nkr-153.24 Million (operating CF Nkr-153.24 Million minus capex Nkr0.00) represents -5% of total liabilities (Nkr33.09 Million). Check BGBIO intangible-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Bergenbio ASA Financial Flexibility Index (2015–2024)
Historical Financial Flexibility Index trend for Bergenbio ASA across 10 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Bergenbio ASA.
Annual Financial Flexibility Index for Bergenbio ASA (2015–2024)
Year-by-year free cash flow to debt coverage for Bergenbio ASA. Explore BGBIO operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (NOK) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | -4.63x | Nkr-153.24 Million | Nkr-153.24 Million | Nkr33.09 Million | ▲ +22.6% |
| 2023 | -5.99x | Nkr-280.50 Million | Nkr-280.50 Million | Nkr46.86 Million | ▼ -62.4% |
| 2022 | -3.69x | Nkr-288.23 Million | Nkr-288.23 Million | Nkr78.21 Million | ▲ +20.0% |
| 2021 | -4.61x | Nkr-303.34 Million | Nkr-303.34 Million | Nkr65.81 Million | ▼ -33.8% |
| 2020 | -3.45x | Nkr-234.22 Million | Nkr-234.29 Million | Nkr67.97 Million | ▲ +5.2% |
| 2019 | -3.64x | Nkr-184.08 Million | Nkr-184.15 Million | Nkr50.62 Million | ▲ +19.0% |
| 2018 | -4.49x | Nkr-186.48 Million | Nkr-186.71 Million | Nkr41.55 Million | ▲ +9.1% |
| 2017 | -4.94x | Nkr-167.77 Million | Nkr-168.11 Million | Nkr33.99 Million | ▲ +15.4% |
| 2016 | -5.83x | Nkr-124.06 Million | Nkr-124.31 Million | Nkr21.27 Million | ▼ -64.3% |
| 2015 | -3.55x | Nkr-62.65 Million | Nkr-62.90 Million | Nkr17.64 Million | — |